drugset / Trial / NCT02259738

Multi-modality MRI Study on Effect to Collateral Circulation and Blood Perfusion of Acute Cerebral Infarction by Human Urinary Kallidinogenase

NCT02259738

Phase 2 Completed 120 enrolled XuanwuH 2
NaSingle-groupSingle-blindTreatment

Summary

Human urinary kallidinogenase can promote the establishment of collateral circulation in the ischemic penumbra due to the stenosis or occlusion of middle cerebral artery and then increase the perfusion.

Timeline

Start
2013-01
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Human Urinary Kallidinogenase Protein / enzyme biologic 0.15 unknown
Subject Shuxuening injection Unknown 20 mg

Indications